(Q53425963)
Statements
CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cell reactivity against autologous leukemic cells in pediatric B-ALL bone marrow. (English)
O Manzke
F Berthold
K Huebel
H Tesch
V Diehl
H Bohlen
1 March 1999
80
5
715-722